ArticlePloS one2026
Prevalence, spatial patterns and determinants of zero-dose vaccination among children aged 12-23 months in Sub-Saharan Africa: A multilevel spatial analysis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVaccination is one of the most cost-effective strategies for enhancing public health and well-being. Despite widespread immunization efforts, zero-dose vaccination among children remains a pressing public health challenge in sub-Saharan Africa (SSA) and there exists a notable gap in research regarding its current burden, spatial distribution and determinants. Hence, this study was aimed at assessing prevalence, spatial patterns and determinants of zero-dose vaccination among children aged 12-23 months in SSA, 2025.
methodsA secondary data analysis of community-based cross-sectional Demographic and Health Survey data from 2015 to 2024 was conducted using a total weighted sample of 58,443 children aged 12-23 months. Descriptive statistics were summarized using texts, tables, and figures, and a multilevel spatial analysis was applied to identify the determinants of zero-dose vaccination. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were computed to determine the level of significance, with a p-value < 0.05 considered statistically significant.
resultsThe prevalence of zero-dose vaccination among children aged 12-23 months in SSA was 13.3% with 95% CI (10.2%, 16.3%). The hot spot clusters were located in most of Nigeria, Angola, Ethiopia, Madagascar, Guinea, Cote d'Ivoire, the southern border of Mauritania, and southeastern of Mali and Mozambique. The poorest household wealth index (AOR = 1.30; 95% CI: 1.10-1.53), home delivery (AOR = 2.60; 95% CI: 2.39-2.83), having no media exposure (AOR = 1.25; 95% CI: 1.14-1.35), no (AOR = 2.41; 95% CI: 2.17-2.68) or low antenatal care visits (AOR = 1.37; 95% CI: 1.26-1.49), having no tetanus toxoid vaccination (AOR = 1.63; 95% CI: 1.49-1.79), having no (AOR = 1.81; 95% CI: 1.62-2.03) or only primary maternal education (AOR = 1.28; 95% CI: 1.16-1.43), perceived problem of distance to health facility (AOR = 1.13; 95% CI: 1.05-1.21) and rural residence (AOR = 1.25; 95% CI: 1.07-1.67) were significantly associated with zero-dose vaccination.
conclusionIn SSA, zero-dose vaccintion was high compared to the global target of no tolerance for zero-dose. The distribution of zero-dose vaccination was spatially clustered with individual and community level factors significantly associated with it. Therefore, spatially targeted interventions taking these factors into account should be implemented by stakeholders in the SSA region to address zero-dose children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.